Elizabeth Phillips

November 12, 2025

New study reveals long-term impacts on Stevens-Johnson syndrome survivors 

SJS and TEN occur when a medication triggers the immune system to attack the body’s own skin and mucous membranes.

By Kylie Avery
November 12, 2025

Eleven Vanderbilt scientists among this year’s ‘highly cited’ researchers

They are among 6,868 scientists worldwide whose papers rank in the top 1% by citations for their fields of research and publication year in the Web of Science Core Collection over the past 11 years.

By Bill Snyder
“The Gout” by British artist James Gillray is a hand-colored soft-ground etching from 1799 and is in the collection of the Metropolitan Museum of Art. (public domain)
October 29, 2025

New genetic marker found to predict severe gout drug reactions in US patients

The discovery could improve safety of allopurinol for millions by expanding genetic screening.

By Craig Boerner
October 2, 2025

New model to assess antibiotic allergies found to benefit transplant patients

By delabeling multiple antibiotics in the same visit, the Vanderbilt Health team can reduce the number of visits from patients.

By Matt Batcheldor
March 27, 2025

Six Vanderbilt faculty elected fellows of international scientific society

One of the world’s largest multidisciplinary scientific societies, the AAAS also publishes the Science family of journals.

By Bill Snyder
November 19, 2024

Eleven Vanderbilt scientists among world’s ‘highly cited’ researchers

The list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges.”

By Bill Snyder
October 16, 2024

Study of severe drug reactions finds skin cells activate their own assassins

Single-cell analysis reveals the inner workings of the life-threatening adverse drug reactions Stevens-Johnson syndrome and toxic epidermal necrolysis.
By Paul Govern
September 18, 2024

Clinic marks 10th year of diagnosis and treatment of drug allergies

The clinic, celebrating its 10th year, has seen groundbreaking discoveries in personalized care and diagnosis for allergy, especially delayed drug allergy, and has advanced discoveries in the optimal process to test patients for drug allergies.
By Nancy Humphrey
November 15, 2023

Twelve at Vanderbilt are among world’s highly cited researchers

Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers.
By Bill Snyder
April 27, 2023

Phillips elected to Association of American Physicians

Vanderbilt's Elizabeth Phillips, MD, has been elected to membership in the Association of American Physicians
By Bill Snyder
September 29, 2022

Penicillin delabeling initiative expanding to more patient care areas

Efforts to correct mistaken or outdated penicillin allergy records are destined to spread to more patient care areas at Vanderbilt University Medical Center.
By Paul Govern
January 24, 2022

Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines

Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children.
By Jessica Pasley
August 12, 2021

Certain drug exposures correlate with reduced COVID severity: study

Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.
By Paul Govern
1 2